![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 17160 |
FusionGeneSummary for IGF2BP3_POLR2B |
![]() |
Fusion gene information | Fusion gene name: IGF2BP3_POLR2B | Fusion gene ID: 17160 | Hgene | Tgene | Gene symbol | IGF2BP3 | POLR2B | Gene ID | 10643 | 5431 |
Gene name | insulin like growth factor 2 mRNA binding protein 3 | RNA polymerase II subunit B | |
Synonyms | CT98|IMP-3|IMP3|KOC|KOC1|VICKZ3 | POL2RB|RPB2|hRPB140 | |
Cytomap | 7p15.3 | 4q12 | |
Type of gene | protein-coding | protein-coding | |
Description | insulin-like growth factor 2 mRNA-binding protein 3IGF-II mRNA-binding protein 3IGF2 mRNA-binding protein 3KH domain containing protein overexpressed in cancerVICKZ family member 3cancer/testis antigen 98 | DNA-directed RNA polymerase II subunit RPB2DNA-directed RNA polymerase II 140 kDa polypeptideDNA-directed RNA polymerase II subunit BRNA polymerase II second largest subunitRNA polymerase II subunit 2RNA polymerase II subunit B2polymerase (RNA) II ( | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | O00425 | P30876 | |
Ensembl transtripts involved in fusion gene | ENST00000258729, ENST00000491719, | ENST00000381227, ENST00000431623, ENST00000441246, ENST00000314595, ENST00000510355, | |
Fusion gene scores | * DoF score | 5 X 5 X 4=100 | 2 X 2 X 2=8 |
# samples | 5 | 2 | |
** MAII score | log2(5/100*10)=-1 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(2/8*10)=1.32192809488736 | |
Context | PubMed: IGF2BP3 [Title/Abstract] AND POLR2B [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | POLR2B | GO:0006366 | transcription by RNA polymerase II | 9852112 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | W81438 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-3CDS | ENST00000258729 | ENST00000381227 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-3CDS | ENST00000258729 | ENST00000431623 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-3CDS | ENST00000258729 | ENST00000441246 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-3CDS | ENST00000258729 | ENST00000314595 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-intron | ENST00000258729 | ENST00000510355 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-3CDS | ENST00000491719 | ENST00000381227 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-3CDS | ENST00000491719 | ENST00000431623 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-3CDS | ENST00000491719 | ENST00000441246 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-3CDS | ENST00000491719 | ENST00000314595 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
intron-intron | ENST00000491719 | ENST00000510355 | IGF2BP3 | chr7 | 23419096 | - | POLR2B | chr4 | 57897082 | - |
Top |
FusionProtFeatures for IGF2BP3_POLR2B |
![]() |
Hgene | Tgene |
IGF2BP3 | POLR2B |
RNA-binding factor that may recruit target transcriptsto cytoplasmic protein-RNA complexes (mRNPs). This transcript'caging' into mRNPs allows mRNA transport and transient storage.It also modulates the rate and location at which targettranscripts encounter the translational apparatus and shields themfrom endonuclease attacks or microRNA-mediated degradation. Bindsto the 3'-UTR of CD44 mRNA and stabilizes it, hence promotes celladhesion and invadopodia formation in cancer cells. Binds to beta-actin/ACTB and MYC transcripts. Binds to the 5'-UTR of theinsulin-like growth factor 2 (IGF2) mRNAs.{ECO:0000269|PubMed:16541107, ECO:0000269|PubMed:23640942}. | DNA-dependent RNA polymerase catalyzes the transcriptionof DNA into RNA using the four ribonucleoside triphosphates assubstrates. Second largest component of RNA polymerase II whichsynthesizes mRNA precursors and many functional non-coding RNAs.Proposed to contribute to the polymerase catalytic activity andforms the polymerase active center together with the largestsubunit. Pol II is the central component of the basal RNApolymerase II transcription machinery. It is composed of mobileelements that move relative to each other. RPB2 is part of thecore element with the central large cleft, the clamp element thatmoves to open and close the cleft and the jaws that are thought tograb the incoming DNA template (By similarity). {ECO:0000250,ECO:0000269|PubMed:9852112}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for IGF2BP3_POLR2B |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for IGF2BP3_POLR2B |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for IGF2BP3_POLR2B |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for IGF2BP3_POLR2B |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | IGF2BP3 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | IGF2BP3 | C0031149 | Peritoneal Neoplasms | 1 | CTD_human |
Hgene | IGF2BP3 | C0345967 | Malignant mesothelioma | 1 | CTD_human |